Back to trial
Eligibility Pre-Screening
Study to Evaluate the Safety and Pharmacokinetics of Topically Applied 40% Lidocaine Gel Compared with Placebo in Subjects With Acute Herpes Zoster (Shingles) Pain
This is a simplified pre-screening tool. Your answers help estimate whether you might qualify, but only the research team can confirm your eligibility. This is not medical advice.
Question 1 of 60%